1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2          Brain Cancer Diagnostics Market – By Cancer Type

1.3.3          Brain Cancer Diagnostics Market – By End User

1.3.4          Middle East and Africa Brain Cancer Diagnostics Market – By Country

2.           Middle East and Africa Brain Cancer Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Middle East and Africa Brain Cancer Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Brain Cancer Diagnostics Market- Middle East and Africa PEST Analysis

4.3          Expert Opinion

5.           Middle East and Africa Brain Cancer Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increase in Prevalence of Brain Cancer

5.1.2          Rise in Number of Cigarette Smokers

5.2          Market Restraints

5.2.1          High Cost of Diagnosis

5.3          Future Trends

5.3.1          Use of Stimulated Raman Histology (SRH)Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4          Impact Analysis

6.           Brain Cancer Diagnostics Market – Middle East and Africa Analysis

6.1          Middle East and Africa Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7.           Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1          Overview

7.2          Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3          Imaging Tests

7.3.1          Overview

7.3.2          Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3          MRI

7.3.3.1             Overview

7.3.3.2             MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4          CT Scan

7.3.4.1             Overview

7.3.4.2             CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5          Positron emission tomography (PET)

7.3.5.1             Overview

7.3.5.2             Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Lumbar Puncture

7.4.1          Overview

7.4.2          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Biopsy

7.5.1          Overview

7.5.2          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Molecular Testing

7.6.1          Overview

7.6.2          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1          Overview

8.2          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3          Astrocytomas

8.3.1          Overview

8.3.2          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Glioblastoma Multiforme

8.4.1          Overview

8.4.2          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Ependymomas

8.5.1          Overview

8.5.2          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Others

8.6.1          Overview

8.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Brain Cancer Diagnostics Market Analysis – By End user

9.1          Overview

9.2          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3          Hospitals

9.3.1          Overview

9.3.2          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Specialty Clinics

9.4.1          Overview

9.4.2          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Ambulatory Surgical Centers

9.5.1          Overview

9.5.2          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1        Middle East and Africa: Brain Cancer Diagnostics Market

10.1.1        Overview

10.1.2        Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1          Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1           Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2           Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1     Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3           Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4           Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.2          UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1           UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2           UAE Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1     UAE Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3           UAE Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4           UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.3          South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1           South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2           South Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1     South Africa Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3           South Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4           South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.4          Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1           Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2           Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1     Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3           Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4           Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on Middle East and Africa Brain Cancer Diagnostics Market

11.1        Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.1        Organic Developments

12.1.1        Overview

12.2        Inorganic Developments

12.2.1        Overview

13.        Company Profiles

13.1        THERMO FISHER SCIENTIFIC INC.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Siemens Healthineers AG

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        GE Healthcare

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Biocept, Inc.

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Koninklijke Philips N.V.

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Canon Medical Systems

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Hitachi, Ltd.

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Neusoft Medical Systems

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

Table 1.              Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3.              Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4.              Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5.              UAE Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 6.              UAE Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 7.              UAE Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 8.              UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 9.              South Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 10.            South Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11.            South Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12.            South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13.            Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028  (USD Million)

Table 14.            Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 15.            Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 16.            Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.            Organic Developments in the Brain Cancer Diagnostics Market

Table 18.            Inorganic Developments in the Brain Cancer Diagnostics Market

Table 19.            Glossary of Terms, Brain Cancer Diagnostics Market

Figure 1.            Brain Cancer Diagnostics Market Segmentation

Figure 2.            Middle East and Africa Brain Cancer Diagnostics Market Overview

Figure 3.            Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4.            Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Brain Cancer Diagnostics Market - Middle East and Africa PEST Analysis

Figure 6.            Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7.            Middle East and Africa Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9.            Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18.          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23.          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.          Middle East and Africa: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.          Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29.          Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.          UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.          South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.          Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.          Impact of COVID-19 Pandemic in Middle East and African Country Markets

Figure 34.          Growth Strategies Done by the Companies in the Market, (%)